CALCB and pancreatic ductal adenocarcinoma: For CALCB, there were 88.89% (56/63) patients showing methylation in the CpG island in pancreatic ductal adenocarcinoma, while only 46.03% (29/63) patients showed methylation in the paracancer tissue.